spacer
home > ebr > autumn 2018 > theory to game changer
PUBLICATIONS
European Biopharmaceutical Review

Theory to Game Changer

Over the past decade, technology has transformed the world. From smartphones and shopping on-demand to selfdriving electric cars, technological advances have altered the way people manage their lives. Such breakthroughs often happened through convergence and gave rise to a new therapeutic class in healthcare known as bioelectronic medicine. The vision of bioelectronic medicine is to use electronic devices to detect and initiate biological changes. Bioelectronics has the potential to significantly impact a person’s wellbeing by giving doctors and patients better alternatives and going beyond the mediation of symptoms. Over the past years, this field has attracted investments from companies as GSK, General Electric, Google Life Sciences, and others. Pioneers are therefore convinced that electronic devices could one day result in a novel class of medicines.

When Electronics Meets Biology

Bioelectronics is an emerging field where technology and science converge. It is a new approach to treat and diagnose various diseases and injuries by using electronic devices harnessing the electrical language of the body. By using electrical pulses generated and delivered by external or implanted devices, hormone, and enzyme activity, aberrant or diseased processes can either be altered or corrected. One aspect of bioelectronics is the detection and characterisation of the electrical properties of biological matter. Another aspect is to interfere and treat diseases on the cellular and subcellular level by stimulating the body’s natural mechanisms. In general, the basic concept of bioelectronic medicine is relatively easy: electric currents create disease-fighting effects and trick the human body into healing.

The Evolution of Bioelectronic Medicine

Implanting or externally stimulating specific body parts with electronic devices that read and/or modulate electric signals often sounds like science fiction. Despite its futuristic connotation, the idea of using electrical stimulation to treat medical conditions is not new. Ancient Egyptians were already intrigued by electricity and used electric fish to control pain. On the other hand, electric rays, a group of fish that produce electrical discharge, were also used by the ancient Greeks. Here, electric shocks were used to numb the pain of childbirth and surgery and treat patients suffering from gout.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Pascaline Vancraeyenest is Clinical Project Manager with Healtech, Magna Cum Laude graduate, and thesis prize winner of Biomedical Science at the KU Leuven in 2013. She obtained her experience by working as a doctoral fellow at the laboratory of neuro- and psychophysiology of the KU Leuven, where she collaborated with several worldleading institutions and universities. As the daughter of one of the pioneers in bioelectronic medicine and founders of Healtech, it allowed Pascaline to obtain a unique perspective on the impact of electronic devices in healthcare.
spacer
Pascaline Vancraeyenest
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

Advanced BioDesign Outlines Solutions

Advanced BioDesign

Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >>

 
Industry Events

World Vaccine Congress Washington

7-9 April 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement